Peptide-based biotech Rhythm Pharmaceuticals sets terms for $100 million IPO

Peptide-based biotech Rhythm Pharmaceuticals sets terms for $100 million IPO | Boulder Peptide Symposium

September 15-18, 2025

LIVE, In Person at the St. Julien Hotel in Boulder, Colorado

The only conference focused solely on the pharmaceutical development of peptide therapeutics.

Peptide-based biotech Rhythm Pharmaceuticals sets terms for $100 million IPO

Peptide News from Biotech and Pharma, Raw News September 25, 2017

Rhythm Pharmaceuticals, a clinical-stage biotech developing peptide-based therapies to treat genetic obesity, announced terms for its IPO on Monday ...